AnaptysBio, Inc.ANABNASDAQ

52-Week Range15-68

15.40Current 64.1168.39

Want to monitor ANAB?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Gross Margin

Operating Margin

Revenue Growth

founded in 2005, anaptysbio, inc.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why

KBR Lands Libya Deal With Zallaf: Is the Expansion a New Growth Lever?

Globale Online (GLBE) Upgraded to Strong Buy: Here's Why

What Makes MYR Group (MYRG) a Strong Momentum Stock: Buy Now?

All You Need to Know About International Consolidated Airlines Group (ICAGY) Rating Upgrade to Strong Buy

Adecoagro (AGRO) Upgraded to Strong Buy: Here's What You Should Know

All You Need to Know About Recruit Holdings Co. (RCRUY) Rating Upgrade to Buy

Comfort Systems (FIX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Mama's Creations, Inc. (MAMA) Upgraded to Strong Buy: Here's What You Should Know

Q32 Bio (QTTB) Upgraded to Strong Buy: Here's What You Should Know

Adlai Nortye Ltd. Sponsored ADR (ANL) Upgraded to Buy: Here's Why

Blue Bird (BLBD) Upgraded to Strong Buy: Here's What You Should Know

HBT Financial (HBT) Upgraded to Buy: Here's What You Should Know

Quebec Innovative Materials Corp. to Host Live X Spaces Q&A on DDH-26-02 Results from West Advocate Hydrogen Project, Nova Scotia

Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange

Glencore could walk away from South Africa smelter rescue talks over conditions

Novo Nordisk's Higher Dose Wegovy Weight-Loss Drug Gains U.S. Approval

Oracle Pushes Up Capex Spending on AI: High Risk or High Reward?

Darden Q3 Earnings Meet Estimates, Revenues Top, Both Rise Y/Y

How Much Does Management Matter For A Publicly Traded Company?

About